Quote
—
—
We have scored 45 news catalysts on TMO (TMO) over the past 12 months. Coverage across the window leans positive (average ticker sentiment +0.30). Most of the impact sits in sector healthcare and institutional appeal.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
—
Open
—
Prev close
—
Volume
—
Avg volume
—
Dividend
—
IPO
—
No scored news tagged TMO or its network in the window yet.
Show more TMO articles →Analysts publish price targets on TMO, and they disagree. Where the share price actually sits among them shows which of their arguments the market is buying — and which it is ignoring.
11 analyst price targets from $510 to $748
as of 2026-09-24
The market is 11% above the median target — more optimistic than the analysts.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about TMO — not a sector bucket. Click an edge to see the articles that established the link.
Suppliers, customers, partners and competitors of TMO, taken from what the news actually said about them rather than from a sector bucket. The count is how many articles established each link.
Latest scored catalyst for TMO: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The reconstruction
The price sits 11% above the median published target and at the 82nd percentile of the model spread, meaning it leans bullish and already pays for a growth acceleration that the company has not yet delivered.
What the disagreement turns on
Can Thermo Fisher's organic revenue growth actually accelerate from the mid-single-digits delivered in early 2026 toward the 16.5% CAGR the current price requires, and the available wired data (unit_volumes via segment revenue history) can measure whether this acceleration is happening quarter by quarter.
The price pays for
It declines to pay for
Written by a language model from the published models, the reported segments and a reverse-DCF — not a recommendation, and not a house view.
Claim by claim
